top of page
Hyperfine Studios partnered with Vicore to create a mechanism of action for their drug candidate ATRAG. The drug promotes alveolar repair and maintenance of alveolar integrity in idiopathic pulmonary fibrosis (IPF). IPF is a condition in which the lungs become scarred, and breathing becomes increasingly difficult. There’s no cure for IPF at the moment.
The primary goal of the animation was to explain the mechanism of action for ATRAGs in an easy-to-understand and visually appealing way. The client also wished the animation to differentiated them from the competitors.
bottom of page